By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Selexis SA 

177 Post Street, Suite 900

San Francisco  California  94108  U.S.A.
Phone: 415-273-5141 Fax: 415-421-5510



Start Up

Company News
Selexis SA Generated Research Cell Banks Now Fully Sequenced Using Next-Generation Sequencing 1/23/2015 11:34:16 AM
First Selexis SA SUREtechnology Generated Therapeutic Monoclonal Antibody Approved For Market 1/8/2015 11:11:41 AM
Symphogen A/S Licenses The Selexis SA SUREtechnology Expression Platform And Cell Line 12/9/2014 11:29:21 AM
Cook Pharmica LLC And Selexis SA Establish Customized Biologic Drug Development And Manufacturing Services Platform 6/24/2014 10:13:58 AM
Selexis SA To Showcase Revolutionary Advancements In Protein Expression Technologies At BIO 2014 6/5/2014 9:17:00 AM
Opthea Signs Cell Line Development Commercial License Agreement With Selexis SA For Wet AMD Product 1/14/2014 10:40:35 AM
Ligand Pharmaceuticals Inc. (LGND) Buys Rights to Programs From Selexis SA 4/30/2013 7:32:13 AM
Selexis SA Announces Expansion of R&D License Agreement With Amgen (AMGN) 2/20/2013 10:25:23 AM
Selexis SALubris Partnership Advances Difficult-to-Express Protein Towards Clinic 6/28/2012 10:18:46 AM
Selexis SA Appoints Yemi Onakunle as Vice President of Strategic and Market Development 1/9/2012 10:39:57 AM